397 Health-related quality of life following [18F]FDG-PET/CT 7 Mean difference over time, within group Baseline v 3 months Baseline v 6 months Baseline v 12 months 3 v 12 months mean diff p† mean diff p† mean diff p† mean diff p† -3.0 0.44 -5.6 0.11 -2.2 0.46 0.8 0.83 -3.3 0.08 -4.8 0.04 -4.4 0.04 -1.1 0.64 1.1 0.69 -0.3 0.92 2.3 0.35 1.2 0.62 -4.8 0.39 -6.7 0.23 -1.7 0.78 3.1 0.63 -11.7 0.002 -6.9 0.06 -5.6 0.11 6.1 0.13 0.9 0.85 -0.8 0.86 1.8 0.57 0.9 0.82 -0.7 0.29 -11.0 0.03 -8.5 0.14 -1.6 0.81 -13.7 <0.001 -9.1 0.008 -6.6 0.04 7.1 0.06 0.2 0.97 0.7 0.84 -0.4 0.91 -0.2 0.96 -2.1 0.74 -1 0.85 5.6 0.21 7.6 0.18 -7.0 0.03 -5.1 0.21 1.3 0.68 8.3 0.02 3.3 0.55 2.5 0.68 4.4 0.39 1.1 0.84 4.5 0.18 -3.3 0.36 1.3 0.67 7.3 0.09 -2.0 0.35 -3.6 0.13 -2.8 0.21 -0.7 0.78 -2.7 0.55 -0.4 0.90 0.90 0.76 3.7 0.35 -3.7 0.38 -4.3 0.21 -3.0 0.53 0.7 0.88 -4.7 0.10 -3.4 0.19 -3.7 0.16 1.0 0.72 -1.1 0.77 0.5 0.90 0.8 0.80 1.9 0.57 -7.5 0.22 -4.7 0.34 -1.0 0.81 6.5 0.31 -8.1 0.006 -4.5 0.15 -7.5 0.01 0.6 0.87 -0.9 0.84 -0.8 0.85 -2.5 0.44 -1.6 0.73 -2.7 0.49 -4.6 0.13 1.3 0.64 4.0 0.30 -0.7 0.74 0.1 0.97 -0.8 0.71 -0.1 0.97 2.1 0.51 0.8 0.83 4.4 0.14 2.3 0.44 2.5 0.71 5.3 0.52 17.6 0.01 15.1 0.07 2.7 0.48 6.4 0.22 7.4 0.18 4.7 0.42 9.6 0.08 16.2 0.02 9.8 0.09 0.21 0.97 -1.9 0.32 -2.9 0.06 -1.6 0.27 0.4 0.84 -2.4 0.008 -1.6 0.10 -2.5 0.005 -0.2 0.87 0.4 0.76 -0.2 0.89 0.3 0.78 -0.1 0.92 -1.8 0.38 -1.1 0.53 0.8 0.63 2.6 0.19 -2.4 0.03 -2.0 0.12 -0.5 0.66 1.9 0.11 -0.4 0.86 0.3 0.86 0.9 0.50 1.3 0.43 For the RAND-36, scores range from 0 (worst score) to 100 (best score). *: P value indicates the between-group difference for that assessment, using an independent samples t-test and using the benign histopathology group as reference category (ref.). †: P value indicates whether the within-group difference between two assessments is statistically significant, using a paired samples t-test.
RkJQdWJsaXNoZXIy MTk4NDMw